Across the recent three months, 19 analysts have shared their insights on Sage Therapeutics (NASDAQ:SAGE), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 12 | 1 | 1 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 3 | 0 | 1 |
| 2M Ago | 0 | 1 | 6 | 0 | 0 |
| 3M Ago | 1 | 2 | 3 | 1 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Sage Therapeutics, presenting an average target of $19.63, a high estimate of $29.00, and a low estimate of $8.00. This current average has decreased by 22.32% from the previous average price target of $25.27.
Decoding Analyst Ratings: A Detailed Look
The standing of...
Login or create a forever free account to read this news
Sign up/Log in